Related Experiment Video
Updated: Nov 3, 2025

14:14
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
16.0K
Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities.
Yu-Ping Yang1, Teresa M Giret2, Richard J Cote3
1Department of Biochemistry and Molecular Biology, DJTMF Biomedical Nanotechnology Institute, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Cancers
|June 2, 2021
Summary
Circulating tumor cells (CTCs) are key to metastasis. Advances in CTC isolation and analysis offer new potential for early cancer detection, prognosis, and personalized medicine strategies.
Area of Science:
- Oncology
- Biomarkers
- Metastasis Research
Background:
- Circulating tumor cells (CTCs) are recognized as critical drivers of distant metastasis.
- CTCs serve as potential biomarkers for early cancer diagnosis, prognosis, and monitoring treatment efficacy.
- Recent research has focused on improving CTC isolation techniques for higher recovery and purity.
Purpose of the Study:
- To review existing CTC isolation technologies.
- To highlight advancements in downstream analysis of CTCs.
- To discuss the clinical applications of CTCs in precision medicine.
Main Methods:
- Summary of current CTC isolation methods.
- Focus on novel downstream analytical techniques for CTCs.
- Exploration of CTC interactions with other cells in circulation.
Main Results:
- Improved CTC isolation techniques have enhanced detection sensitivity and enumeration accuracy.
- Significant progress in molecular characterization and ex vivo expansion of CTCs.
- Growing understanding of CTC interactions with immune and stromal cells.
Conclusions:
- Advances in CTC analysis are paving the way for precision medicine applications.
- Further research is needed to overcome challenges in clinical CTC utilization.
- CTCs hold significant promise for improving cancer patient outcomes.

